Post-Doctoral Fellow – National Institute Drug Abuse
Listed on 2026-01-27
-
Healthcare
Clinical Research
Overview
Post-Doctoral Fellow – National Institute on Drug Abuse
The Clinical Psychoneuroendocrinology and Neuropsychopharmacology (CPN) Section is a translational and clinical laboratory of the NIH Intramural Research Program, jointly funded by NIDA and NIAAA, currently recruiting a Post-Doctoral Fellow. The workplace is located in Baltimore, MD.
The Post-Doctoral fellow will be involved in a variety of projects and clinical protocols relevant to the laboratory, under the supervision and mentoring of Dr. Lorenzo Leggio, Principal Investigator, Senior Investigator (Clinical) and Chief. The laboratory conducts human clinical and translational inpatient and outpatient studies to identify possible novel medications for addiction. The goal of these studies is to identify and develop novel effective treatments for alcohol and substance use disorders.
The focus is on studying novel pathways related to the microbiome-gut-liver-brain axis, neuroendocrine pathways, and other approaches aimed at improving understanding and treatment of addictions. The selected candidate will have access to lectures, educational, mentoring and grant training opportunities at the lab-level, and NIH-wide.
The Post-Doctoral Fellow will contribute to ongoing projects and clinical protocols within the laboratory, under supervision and mentoring.
To applySend current CV, a statement of research background and interests, and at least 3 reference contacts to:
Dr. Lorenzo Leggio, M.D., Ph.D., Email: lorenzo.leggio
Contact name:
Dr. Lorenzo Leggio
Contact email: lorenzo.leggio
- An M.D., Ph.D., or equivalent degree is required.
- The ideal candidate will have a strong background and skillset related to addiction, mental health and neuroscience.
- Experience in carrying over experimental medicine and human laboratory studies with research volunteers, including participants with alcohol and substance use disorders, is preferred.
(If this job is in fact in your jurisdiction, then you may be using a Proxy or VPN to access this site, and to progress further, you should change your connectivity to another mobile device or PC).